William Beaumont Hospitals Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2011
NCT01325779
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Beaumont Hospital | Beaumont Hospital, Royal Oak. Michigan | Beaumont RCSI Cancer Centre, Beaumont Hospital | Jason Gilleran | Lisa Louwers | RCSI Education & Research Centre, Beaumont Hospital, Beaumont Dublin 9 Ireland Ireland

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 2)

Coronary Disease (Phase 2)

Heart Diseases (Phase 2)

Heart Valve Diseases (Phase 2)

Ischemia (Phase 2)

Myocardial Ischemia (Phase 2)

Pancreatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 12